Objective To evaluate the diagnostic performance of HE4 and CA125 in patients presenting
with suspicious malignant ovarian cysts. We especially wanted to investigate the levels of …

Ovarian cancer (OC) is the most lethal gynaecologic malignancy, attributed to its insidious
growth, non-specific symptoms and late presentation. Unfortunately, current screening …

Objective The objective of this study is to externally validate the KELIM (rate of elimination of
CA-125 elimation) score in patients with high grade serous ovarian cancer (HGSC) …

Objective There are no current guidelines regarding evaluation of patients with normal
CA125 at initial diagnosis during routine surveillance after completion of treatment. Thus, the …

The purpose of the study was to evaluate the expression of the biomarkers CA125 and HE4
combined with imaging, in patients with advanced epithelial ovarian cancer (EOC). Forty-six …

For recurrent ovarian cancer (ROC), secondary cytoreductive surgery (SCS) is
recommended as one optional treatment. However, little is known about the expression and …

OBJECTIVE: To evaluate the utility of serum (HE4) as a marker for high risk disease in
patients with endometrial cancer (EC). METHODS: Preoperative serum HE4 levels were …

Objective To investigate serum human epididymis‐4 (HE4) as a predictive biomarker of
intrauterine progestin response in endometrial cancer and atypical endometrial hyperplasia …

Purpose of investigation: The aim of this work was to compare serum concentrations of HE4
in patients with benign and malignant epithelial tumors and to determine the association of …

Objectives To examine the prognostic significance, in patients with ovarian cancer, of
normalization of CA125 levels in serum during neoadjuvant chemotherapy treatment …